DAWN COOPER: Open Payments
NPI 1558731497 · SEWELL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 24 payments from 10 companies in 2025. Trend: 2023 $155 · 2024 $173 · 2025 $521
Food & beverage: $521
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $156 |
| GlaxoSmithKline, LLC. | 4 | $69 |
| Novo Nordisk Inc | 4 | $68 |
| Astellas Pharma US Inc | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| Exact Sciences Corporation | 2 | $38 |
| PFIZER INC. | 2 | $33 |
| SANOFI PASTEUR INC. | 1 | $23 |
| Lilly USA, LLC | 1 | $19 |
| Amgen Inc. | 1 | $18 |
Products named: QULIPTA, Veozah, SHINGRIX, The Cologuard Plus Collection Kit, Ozempic, PREVNAR 20, AIRSUPRA, FLUZONE HIGH-DOSE.
Industry payments across NJ — which companies pay providers there.
